Hancock Whitney’s Boston Scientific BSX Stock Holding History

Hancock Whitney’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$806K	Sell	18,876 -1,651	-8%	-$89.7K	0.01%	480
2026 Q1	$1.28M	Buy	+20,527	New	+$1.64M	0.02%	396
2020 Q1	–	Sell	-12,320	Closed	-$557K	–	830
2019 Q4	$557K	Sell	12,320 -2,308	-16%	-$96.6K	0.02%	544
2019 Q3	$595K	Buy	14,628 +467	+3%	+$19.8K	0.02%	548
2019 Q2	$609K	Sell	14,161 -239	-2%	-$9.19K	0.02%	574
2019 Q1	$553K	Buy	14,400 +144	+1%	+$5.5K	0.02%	596
2018 Q4	$504K	Buy	14,256 +1,501	+12%	+$54.4K	0.02%	576
2018 Q3	$491K	Sell	12,755 -710	-5%	-$24.8K	0.01%	650
2018 Q2	$440K	Buy	+13,465	New	+$406K	0.02%	440

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Hancock Whitney's BSX Position: Q2 2026 in Review

Hancock Whitney reduced its Boston Scientific (BSX) stake by 8% in Q2 2026, selling an estimated $89.7K and leaving 18,876 shares worth $806K. The position accounts for 0.01% of the portfolio, ranked #480.

Hancock Whitney first reported a position in BSX in Q2 2018 and has held it in 9 quarters since. The position peaked at $1.28M in Q1 2026. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Hancock Whitney held 18,876 shares of Boston Scientific worth $806K as of Q2 2026.
Hancock Whitney sold 1,651 Boston Scientific shares in Q2 2026, an estimated $89.7K.
Boston Scientific made up 0.01% of Hancock Whitney's portfolio in Q2 2026, its #480 holding.
Hancock Whitney first reported a position in Boston Scientific in Q2 2018 and has held it in 9 quarters since.
Hancock Whitney's Boston Scientific position peaked at $1.28M in Q1 2026.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Hancock Whitney's 13F filing for Q2 2026, filed 14 Aug 2026.